If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTP ICAP Regulatory News (TCAP)

Share Price Information for TP ICAP (TCAP)

Share Price is delayed by 15 minutes
Get Live Data
347.00    1.40 (0.41%)
Bid:
347.00
Ask:
347.40
Spread: 0.40 (0.115%)
Market Cap: £2.53b
TCAP Live PriceLast checked at - London Stock Exchange

Intraday TP ICAP Share Chart

Directorate change

13 May 2026 16:12

RNS Number : 2188E
TP ICAP Group plc
13 May 2026
 

 

TP ICAP Group plc

LEI: 2138006YAA7IRVKKGE63

13 May 2026

 

TP ICAP Group plc (the 'Company' or 'TP ICAP')

 

Director Changes

 

The Company is pleased to announce the appointment of Jane Guyett and Paul Newman as Independent Non-executive Directors of the Company. Jane's appointment will be effective from 1 July 2026 and Paul's appointment effective from 1 August 2026. On joining the Board Jane will assume the role of Chair of the Remuneration Committee and join the Audit Committee. Paul will join the Risk Committee and be the EMEA Workforce Engagement Director. Both Jane and Paul will join the Nominations & Governance Committee.

 

Jane is currently the Senior Independent Director at Hiscox Group, a Non-Executive Director at Royal London Mutual Insurance Society ('Royal London') and BDO LLP. She Chairs the Remuneration Committees for Hiscox and Royal London and the Risk Oversight Committee at BDO. The majority of Jane's executive career was spent at Bank of America, where she served in leadership roles including COO for Global Markets EMEA & Asia.

 

Paul brings over 40 years of experience in capital markets, wholesale broking, and commodity derivatives. He spent more than 25 years at ICAP plc, where he founded the firm's commodities arm in 1990 and served as Executive Managing Director, and subsequently Chair of ICAP Energy until 2016, and as Chair of ICAP Shipping from 2008 to 2014. He was a director at NEX Group plc from 2016 until its acquisition by CME Group in 2018.

Commenting on Jane and Paul's appointments, Richard Berliand, Chair of TP ICAP Group plc, said:

 

"We are very pleased to welcome both Jane and Paul to the Board of the Company. They both bring substantial capital markets, broking and securities experience from their respective executive career and directorship roles, and each will be a great addition to our Board."

 

The Company also announces that Tracy Clarke and Mark Hemsley, Independent Non-executive Directors, will stand down as Directors of the Company with effect from 30 June 2026. Commenting on their future departure, Richard Berliand, said:

 

"The Board would like to thank both Tracy and Mark for their significant contribution to the Board during their tenure. The insights, challenge, and advice that they have been able to bring to the debate is much appreciated".

 

This announcement is made in accordance with UK Listing Rules 6.4.8R and there are no other additional matters that require disclosure under Listing Rule 6.4.6.

 

 

 

ENDS

 

For further information, please contact:

 

Victoria Hames

Company Secretariat

Email: CompanySecretarial@tpicap.com

 

Derek Brown

Head of Investor RelationsDirect: +44 (0) 20 3933 0447

Email: Derek.brown@tpicap.com

 

Richard Newman

Group Head of Marketing and Communications

Direct: +44 (0) 7469 039 307

Email: Richard.Newman@tpicap.com

 

About TP ICAP Group plc

 

TP ICAP connects buyers and sellers in global financial, energy and commodities markets.

We are the world's leading wholesale market intermediary, with a portfolio of businesses that provide broking services, data & analytics and market intelligence, trusted by clients around the world.

We operate from more than 60 offices across 28 countries, supporting brokers with award-winning and market-leading technology.

 

Further information on the company and its activities is available on the Company's website:

www.tpicap.com.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAEXLFFQELFBBB
Date   Source Headline
6th Apr 20214:32 pmRNSDirector/PDMR Shareholding - Replacement
1st Apr 20216:15 pmRNSDirector/PDMR Shareholding
26th Mar 20212:05 pmRNSAnnual Financial Report
10th Mar 20215:16 pmRNSRe-registration and name change
9th Mar 20217:03 amRNSFinal Results
26th Feb 20218:24 amRNSScheme Effective and Admission
24th Feb 20214:24 pmRNSCourt Sanction of the Scheme of Arrangement
18th Feb 20214:20 pmRNSHolding(s) in Company
17th Feb 20214:00 pmRNSDirector/PDMR Shareholding
17th Feb 20214:00 pmRNSTotal Voting Rights
17th Feb 202111:12 amRNSResults of Rump Placing
17th Feb 20217:00 amRNSResults of Rights Issue
16th Feb 20212:56 pmRNSHolding(s) in Company
2nd Feb 20218:00 amRNSAdmission of Nil Paid Rights
1st Feb 20214:05 pmRNSResults of Court Meeting and General Meeting
1st Feb 20213:55 pmRNSResult of General Meeting - Liquidnet Acquistion
29th Jan 20211:05 pmRNSPublication of Suppl.Prospcts
25th Jan 20217:00 amRNSUpdate on Brexit Readiness Plan
7th Jan 20211:44 pmRNSCorporate Reorganisation - Documents Publication
7th Jan 20211:40 pmRNSPublication of Prospectus and Circular
7th Jan 20217:00 amRNSAnnouncement re: Rights Issue
7th Jan 20217:00 amRNSTrading Statement
17th Dec 202012:25 pmRNSHolding(s) in Company
15th Dec 20203:55 pmRNSHolding(s) in Company
1st Dec 20207:00 amRNSTP ICAP plc hosts its 2020 Capital Markets Day
23rd Nov 202012:39 pmRNSChanges to Committee Membership
12th Nov 20204:24 pmRNSDirector/PDMR Shareholding
10th Nov 20204:28 pmRNSHolding(s) in Company
9th Nov 20207:00 amRNSTrading Statement
3rd Nov 20205:11 pmRNSHolding(s) in Company
30th Oct 20203:38 pmRNSTotal Voting Rights
23rd Oct 202012:13 pmRNSHolding(s) in Company
14th Oct 20205:24 pmRNSDirector/PDMR Shareholding
13th Oct 20204:08 pmRNSDirector/PDMR Shareholding
12th Oct 20203:29 pmRNSDirector/PDMR Shareholding
9th Oct 20203:07 pmRNSDirector/PDMR Shareholding
9th Oct 20207:00 amRNSProposed Acquisition of Liquidnet
29th Sep 20206:26 pmRNSDiscussions re proposed acquisition of Liquidnet
10th Sep 20202:45 pmRNSDirectorate Change
7th Aug 20207:00 amRNSFinancial and Interim Management Report
31st Jul 20201:43 pmRNSAcquisition of Louis Capital
31st Jul 20207:00 amRNSDirectorate Change
6th Jul 202010:58 amRNSHolding(s) in Company
6th Jul 202010:49 amRNSHolding(s) in Company
25th Jun 20208:56 amRNSHolding(s) in Company
24th Jun 202010:31 amRNSDirector/PDMR Shareholding
23rd Jun 20205:18 pmRNSHolding(s) in Company
17th Jun 202012:09 pmRNSHolding(s) in Company
13th May 20206:08 pmRNSResult of AGM
13th May 20207:00 amRNSTrading Update Q1 2020

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.